The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Antineoplastic Agents, Immunological

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Antineoplastic Agents, Immunological.
Olatoyosi Odenike
Connection Strength
0.188
Antineoplastic Agents, Immunological
  1. Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia. Blood Adv. 2025 May 13; 9(9):2144-2152.
    View in: PubMed
    Score: 0.188
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.